233 related articles for article (PubMed ID: 17368633)
1. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
Berthelot C; Dickerson MC; Rady P; He Q; Niroomand F; Tyring SK; Pandya AG
J Am Acad Dermatol; 2007 May; 56(5):882-6. PubMed ID: 17368633
[TBL] [Abstract][Full Text] [Related]
2. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK; Chen JF; Xu AE
Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
[TBL] [Abstract][Full Text] [Related]
3. A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge.
Baskan EB; Tunali S; Adim SB; Turan A; Toker S
J Dermatolog Treat; 2006; 17(3):179-83. PubMed ID: 16854762
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
Kim C; Hashemi P; Caglia M; Shulman K
J Drugs Dermatol; 2016 Mar; 15(3):350-2. PubMed ID: 26954321
[TBL] [Abstract][Full Text] [Related]
6. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
[TBL] [Abstract][Full Text] [Related]
7. Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
Yoshida R; Kato T; Kawase M; Honda M; Mitsuishi T
BMC Dermatol; 2014 Jul; 14():12. PubMed ID: 25048734
[TBL] [Abstract][Full Text] [Related]
8. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.
Ramoz N; Rueda LA; Bouadjar B; Montoya LS; Orth G; Favre M
Nat Genet; 2002 Dec; 32(4):579-81. PubMed ID: 12426567
[TBL] [Abstract][Full Text] [Related]
9. Epidermodysplasia verruciformis in lipoid proteinosis: case report and discussion of pathophysiology.
O'Blenes C; Pasternak S; Issekutz A; Gillis J; Chowdhury D; Finlayson L
Pediatr Dermatol; 2015; 32(1):118-21. PubMed ID: 23534907
[TBL] [Abstract][Full Text] [Related]
10. Development of aggressive squamous cell carcinoma in epidermodysplasia verruciformis associated with human papillomavirus type 22b.
Kim T; Park JC; Roh MR; Park JM; Kim SH; Cho NH; Lee MG
Dermatology; 2010; 220(4):326-8. PubMed ID: 20460877
[TBL] [Abstract][Full Text] [Related]
11. Homozygosity for the c.917A→T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz.
Arnold AW; Burger B; Kump E; Rufle A; Tyring SK; Kempf W; Häusermann P; Itin PH
Dermatology; 2011 Feb; 222(1):81-6. PubMed ID: 21196704
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
Przybyszewska J; Zlotogorski A; Ramot Y
J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
[TBL] [Abstract][Full Text] [Related]
13. Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma.
Li SL; Duo LN; Wang HJ; Dai W; Zhou EH; Xu YN; Zhao T; Xiao YY; Xia L; Yang ZH; Zheng LT; Hu YY; Lin ZM; Wang HN; Gao TW; Ma CL; Yang Y; Li CY
Br J Dermatol; 2016 Dec; 175(6):1204-1209. PubMed ID: 27087313
[TBL] [Abstract][Full Text] [Related]
14. Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient.
Gober MD; Rady PL; He Q; Tucker SB; Tyring SK; Gaspari AA
J Invest Dermatol; 2007 Apr; 127(4):817-20. PubMed ID: 17139267
[TBL] [Abstract][Full Text] [Related]
15. [Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream].
Heratizadeh A; Völker B; Kupsch E; Wichmann K; Kapp A; Werfel T
Hautarzt; 2010 Dec; 61(12):1052-5. PubMed ID: 20824263
[TBL] [Abstract][Full Text] [Related]
16. [Squamous cell carcinoma developing from epidermodysplasia verruciformis].
Gross C; Basten D; Langner C
Pathologe; 1999 Mar; 20(2):120-4. PubMed ID: 10321000
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis.
Zuo YG; Ma D; Zhang Y; Qiao J; Wang B
J Dermatol Sci; 2006 Dec; 44(3):153-9. PubMed ID: 17008061
[TBL] [Abstract][Full Text] [Related]
18. Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod.
MacFarlane DF; El Tal AK
Arch Dermatol; 2011 Nov; 147(11):1326-7. PubMed ID: 22106125
[No Abstract] [Full Text] [Related]
19. Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene.
Landini MM; Zavattaro E; Borgogna C; Azzimonti B; De Andrea M; Colombo E; Marenco F; Amantea A; Landolfo S; Gariglio M
J Invest Dermatol; 2012 Apr; 132(4):1305-8. PubMed ID: 22158547
[No Abstract] [Full Text] [Related]
20. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
